Editorial Board — Medscape Pulmonary Medicine


James F. Donohue, MD
James F. Donohue, MD

Professor of Medicine, School of Medicine, University of North Carolina, Chapel Hill

James F. Donohue, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Mylan Laboratories Inc.; Sunovion Pharmaceuticals
Received income in an amount equal to or greater than $250 from: AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Mylan Laboratories Inc.; Sunovion Pharmaceuticals


Nicholas J. Gross, MD, PhD
Nicholas J. Gross, MD, PhD

Professor Emeritus, Stritch-Loyola School of Medicine, University of Chicago School of Medicine, Hyde Park, Chicago, Illinois; Volunteer Physician, St. Francis Hospital, Hartford, Connecticut

Nicholas J. Gross, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Mylan Laboratories Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP
Serve(d) as a speaker or a member of a speakers bureau for: Mylan Laboratories Inc.


Kim M. Kerr, MD
Kim M. Kerr, MD

Clinical Professor, Department of Medicine, University of California San Diego

Kim M. Kerr, MD, has disclosed the following relevant financial information:
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals
Received grants for clinical research from: Bayer HealthCare Pharmaceuticals


Sumita Khatri, MD
Sumita Khatri, MD

Assistant Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine; Co-director, Asthma Center, Respiratory Institute, The Cleveland Clinic, Cleveland, Ohio

Sumita Khatri, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: GlaxoSmithKline; Teva Pharmaceuticals USA; Centocor Biotech, Inc.; Boston Scientific.


Christopher J. Lettieri
Christopher J. Lettieri, MD

Professor of Medicine, Uniformed Services University of the Health Sciences; Program Director, Sleep Medicine Fellowship, National Capital Consortium, Bethesda, Maryland; Pulmonary and Critical Care Medicine Consultant to the Army Surgeon General, US Army, Annandale, Virginia

Christopher J. Lettieri, MD, has disclosed no relevant financial relationships.


Steven Nathan, MD
Steven Nathan, MD

Professor of Medicine, Virginia Commonwealth University; Medical Director, Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia

Steven D. Nathan, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Actelion Pharmaceuticals, Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Gilead Sciences, Inc.; Genentech; United Therapeutics
Serve(d) as a speaker or member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc..; Bayer HealthCare Pharmaceuticals; Gilead Sciences, Inc.; Genentech; United Therapeutics
Received research grant from: Actelion Pharmaceuticals, Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Gilead Sciences, Inc.; United Therapeutics; Veracyte
Received income in an amount equal to or great than $250 from: Actelion Pharmaceuticals, Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Gilead Sciences, Inc.; Genentech; United Therapeutics


Andrew F. Shorr, MD, MPH, FACP, FCCP
Andrew F. Shorr, MD, MPH, FACP, FCCP

Associate Professor of Medicine, Division of Pulmonary & Critical Care Medicine, Georgetown University; Director (Interim), Section of Pulmonary & Critical Care Medicine; Director, Medical Intensive Care Unit, Medstar Washington Hospital Center, Washington, DC

Andrew Shorr, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant, speaker, or has received research support from: AstraZeneca Pharmaceuticals LP; Astellas Pharma, Inc; Allergan, Inc; Abbott Laboratories; Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb Company; Endoclear; The Medicines Company; Melinta; Merck & Co. Inc; Nabriva; Pfizer Inc; Roche; Tetraphase; Theravance, Inc.